Tyler Heather L, Haron Mona H, Pugh Nirmal D, Zhang Jin, Jackson Colin R, Pasco David S
Crop Production Systems Research Unit, USDA Agricultural Research Service, P.O. Box 350, Stoneville, MS 32776, USA and Department of Biology, The University of Mississippi, P.O. Box 1848, University, MS 38677-1848, USA.
National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, P.O. Box 1848, University, MS 38677-1848, USA.
Food Funct. 2016 Oct 12;7(10):4213-4221. doi: 10.1039/c6fo00562d.
Recent studies have indicated that a major contributor to the innate immune enhancing properties of some medicinal plants is derived from the cell wall components of bacteria colonizing these plants. The purpose of the current study was to assess if the bacteria present within edible and medicinal mushrooms substantially contribute to the innate immune stimulating potential of these mushrooms. Whole mushrooms from thirteen types of edible fungi and individual parts from Agaricus bisporus were analyzed for in vitro macrophage activation as well as bacterial lipopolysaccharides (LPS) content, cell load, and community composition. Substantial variation between samples was observed in macrophage activation (over 500-fold), total bacterial load (over 200-fold), and LPS content (over 10 million-fold). Both LPS content (ρ = 0.832, p < 0.0001) and total bacterial load (ρ = 0.701, p < 0.0001) correlated significantly with macrophage activation in the whole mushroom extracts. Extract activity was negated by treatment with NaOH, conditions that inactivate LPS and other bacterial components. Significant correlations between macrophage activation and total bacterial load (ρ = 0.723, p = 0.0001) and LPS content (ρ = 0.951, p < 0.0001) were also observed between different tissues of Agaricus bisporus. Pseudomonas and Flavobacterium were the most prevalent genera identified in the different tissue parts and these taxa were significantly correlated with in vitro macrophage activation (ρ = 0.697, p < 0.0001 and ρ = 0.659, p = 0.0001, respectively). These results indicate that components derived from mushroom associated bacteria contribute substantially to the innate immune enhancing activity exhibited by mushrooms and may result in similar therapeutic actions as reported for ingestion of bacterial preparations such as probiotics.
最近的研究表明,一些药用植物具有先天免疫增强特性的一个主要因素源自定殖于这些植物的细菌的细胞壁成分。本研究的目的是评估食用蘑菇和药用蘑菇中存在的细菌是否对这些蘑菇的先天免疫刺激潜力有实质性贡献。对13种食用真菌的完整蘑菇以及双孢蘑菇的各个部分进行了体外巨噬细胞激活分析,以及细菌脂多糖(LPS)含量、细胞载量和群落组成分析。在巨噬细胞激活(超过500倍)、总细菌载量(超过200倍)和LPS含量(超过1000万倍)方面,观察到样本之间存在显著差异。在完整蘑菇提取物中,LPS含量(ρ = 0.832,p < 0.0001)和总细菌载量(ρ = 0.701,p < 0.0001)均与巨噬细胞激活显著相关。用NaOH处理可使提取物活性丧失,NaOH处理条件会使LPS和其他细菌成分失活。在双孢蘑菇的不同组织之间,也观察到巨噬细胞激活与总细菌载量(ρ = 0.723,p = 0.0001)和LPS含量(ρ = 0.951,p < 0.0001)之间存在显著相关性。假单胞菌属和黄杆菌属是在不同组织部分中鉴定出的最常见属,这些分类群与体外巨噬细胞激活显著相关(分别为ρ = 0.697,p < 0.0001和ρ = 0.659,p = 0.0001)。这些结果表明,源自蘑菇相关细菌的成分对蘑菇表现出的先天免疫增强活性有实质性贡献,并且可能产生与摄入益生菌等细菌制剂所报道的类似治疗作用。